Skip to main content
. 2019 Feb 14;8(4):1882–1892. doi: 10.1002/cam4.2012

Figure 2.

Figure 2

Tumor markers, hormone levels, and breast cancer subtypes. (A) CA153, (B) CA125, (C) CEA, and (D) combined three markers; (E) prolactin (PRL), (F) testosterone, (G) follicle‐stimulating hormone (FSH), (H) estradiol (E2), (I) progesterone, (J) luteinizing hormone (LH), and (K) combined six hormones